PortfoliosLab logoPortfoliosLab logo
NVNO vs. PANW
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

NVNO vs. PANW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in enVVeno Medical Corporation (NVNO) and Palo Alto Networks, Inc. (PANW). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NVNO vs. PANW - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
NVNO
enVVeno Medical Corporation
-8.27%-89.38%-41.25%0.78%-22.61%-23.82%-37.09%-62.71%-71.85%
PANW
Palo Alto Networks, Inc.
-12.77%1.23%23.41%111.32%-24.81%56.66%53.68%22.78%-9.49%

Fundamentals

Market Cap

NVNO:

$6.07M

PANW:

$114.56B

EPS

NVNO:

-$93.91

PANW:

$1.81

PB Ratio

NVNO:

0.22

PANW:

12.20

Total Revenue (TTM)

NVNO:

$0.00

PANW:

$9.89B

Gross Profit (TTM)

NVNO:

-$372.00K

PANW:

$7.27B

EBITDA (TTM)

NVNO:

-$19.38M

PANW:

$2.04B

Returns By Period

In the year-to-date period, NVNO achieves a -8.27% return, which is significantly higher than PANW's -12.77% return.


NVNO

1D
1.68%
1M
1.08%
YTD
-8.27%
6M
-67.68%
1Y
-88.46%
3Y*
-60.23%
5Y*
-46.65%
10Y*

PANW

1D
0.22%
1M
7.01%
YTD
-12.77%
6M
-22.31%
1Y
-6.21%
3Y*
17.17%
5Y*
24.06%
10Y*
19.59%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NVNO vs. PANW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVNO
NVNO Risk / Return Rank: 1010
Overall Rank
NVNO Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
NVNO Sortino Ratio Rank: 99
Sortino Ratio Rank
NVNO Omega Ratio Rank: 77
Omega Ratio Rank
NVNO Calmar Ratio Rank: 55
Calmar Ratio Rank
NVNO Martin Ratio Rank: 1616
Martin Ratio Rank

PANW
PANW Risk / Return Rank: 3232
Overall Rank
PANW Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
PANW Sortino Ratio Rank: 2929
Sortino Ratio Rank
PANW Omega Ratio Rank: 2929
Omega Ratio Rank
PANW Calmar Ratio Rank: 3636
Calmar Ratio Rank
PANW Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVNO vs. PANW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for enVVeno Medical Corporation (NVNO) and Palo Alto Networks, Inc. (PANW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NVNOPANWDifference

Sharpe ratio

Return per unit of total volatility

-0.73

-0.17

-0.56

Sortino ratio

Return per unit of downside risk

-1.09

0.01

-1.10

Omega ratio

Gain probability vs. loss probability

0.83

1.00

-0.17

Calmar ratio

Return relative to maximum drawdown

-0.93

-0.16

-0.77

Martin ratio

Return relative to average drawdown

-1.25

-0.41

-0.84

NVNO vs. PANW - Sharpe Ratio Comparison

The current NVNO Sharpe Ratio is -0.73, which is lower than the PANW Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of NVNO and PANW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NVNOPANWDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.73

-0.17

-0.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.58

0.60

-1.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.57

0.61

-1.18

Correlation

The correlation between NVNO and PANW is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NVNO vs. PANW - Dividend Comparison

Neither NVNO nor PANW has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NVNO vs. PANW - Drawdown Comparison

The maximum NVNO drawdown since its inception was -99.81%, which is greater than PANW's maximum drawdown of -47.98%. Use the drawdown chart below to compare losses from any high point for NVNO and PANW.


Loading graphics...

Drawdown Indicators


NVNOPANWDifference

Max Drawdown

Largest peak-to-trough decline

-99.81%

-47.98%

-51.83%

Max Drawdown (1Y)

Largest decline over 1 year

-95.28%

-36.01%

-59.27%

Max Drawdown (5Y)

Largest decline over 5 years

-97.66%

-36.01%

-61.65%

Max Drawdown (10Y)

Largest decline over 10 years

-47.98%

Current Drawdown

Current decline from peak

-99.78%

-27.42%

-72.36%

Average Drawdown

Average peak-to-trough decline

-89.75%

-14.72%

-75.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

70.94%

14.28%

+56.66%

Volatility

NVNO vs. PANW - Volatility Comparison

enVVeno Medical Corporation (NVNO) has a higher volatility of 24.63% compared to Palo Alto Networks, Inc. (PANW) at 12.10%. This indicates that NVNO's price experiences larger fluctuations and is considered to be riskier than PANW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NVNOPANWDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.63%

12.10%

+12.53%

Volatility (6M)

Calculated over the trailing 6-month period

81.30%

25.19%

+56.11%

Volatility (1Y)

Calculated over the trailing 1-year period

121.78%

36.72%

+85.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

81.30%

40.60%

+40.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

94.32%

38.47%

+55.85%

Financials

NVNO vs. PANW - Financials Comparison

This section allows you to compare key financial metrics between enVVeno Medical Corporation and Palo Alto Networks, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
2.59B
(NVNO) Total Revenue
(PANW) Total Revenue
Values in USD except per share items